A detailed history of Cortland Associates Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Cortland Associates Inc holds 1,657 shares of JNJ stock, worth $272,477. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,657
Previous 1,656 0.06%
Holding current value
$272,477
Previous $261,000 7.28%
% of portfolio
0.03%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$144.38 - $157.78 $144 - $157
1 Added 0.06%
1,657 $242,000
Q1 2024

Apr 22, 2024

SELL
$155.22 - $162.74 $11,486 - $12,042
-74 Reduced 4.28%
1,656 $261,000
Q4 2023

Jan 30, 2024

BUY
$145.6 - $158.88 $145 - $158
1 Added 0.06%
1,730 $271,000
Q3 2023

Oct 27, 2023

SELL
$155.75 - $174.48 $5,918 - $6,630
-38 Reduced 2.15%
1,729 $269,000
Q2 2023

Aug 03, 2023

BUY
$154.35 - $166.11 $154 - $166
1 Added 0.06%
1,767 $292,000
Q1 2023

Apr 20, 2023

SELL
$151.05 - $180.26 $24,923 - $29,742
-165 Reduced 8.54%
1,766 $273,000
Q4 2022

Jan 27, 2023

SELL
$160.2 - $179.79 $12,655 - $14,203
-79 Reduced 3.93%
1,931 $0
Q3 2022

Nov 01, 2022

BUY
$161.33 - $179.52 $5,969 - $6,642
37 Added 1.88%
2,010 $328,000
Q2 2022

Jul 22, 2022

BUY
$168.19 - $186.01 $27,583 - $30,505
164 Added 9.07%
1,973 $350,000
Q1 2022

May 03, 2022

SELL
$158.14 - $179.59 $5,376 - $6,106
-34 Reduced 1.84%
1,809 $321,000
Q4 2021

Feb 01, 2022

BUY
$155.93 - $173.01 $5,457 - $6,055
35 Added 1.94%
1,843 $315,000
Q3 2021

Nov 02, 2021

BUY
$161.5 - $179.47 $161 - $179
1 Added 0.06%
1,808 $292,000
Q2 2021

Aug 02, 2021

BUY
$159.48 - $171.07 $24,400 - $26,173
153 Added 9.25%
1,807 $298,000
Q1 2020

Apr 30, 2020

SELL
$111.14 - $153.99 $40,010 - $55,436
-360 Reduced 17.87%
1,654 $217,000
Q4 2019

Jan 31, 2020

BUY
$127.5 - $146.44 $40,417 - $46,421
317 Added 18.68%
2,014 $294,000
Q3 2019

Nov 07, 2019

SELL
$126.95 - $142.14 $38,085 - $42,641
-300 Reduced 15.02%
1,697 $220,000
Q1 2019

Apr 26, 2019

SELL
$125.72 - $139.79 $22,126 - $24,603
-176 Reduced 8.1%
1,997 $279,000
Q4 2018

Feb 01, 2019

BUY
$122.84 - $147.84 $11,055 - $13,305
90 Added 4.32%
2,173 $280,000
Q3 2018

Oct 30, 2018

SELL
$121.58 - $142.88 $232,947 - $273,758
-1,916 Reduced 47.91%
2,083 $288,000
Q2 2018

Jul 16, 2018

SELL
$119.4 - $131.76 $1,791 - $1,976
-15 Reduced 0.37%
3,999 $485,000
Q4 2017

Jan 24, 2018

BUY
$131.22 - $143.62 $78,732 - $86,172
600 Added 17.57%
4,014 $561,000
Q3 2017

Oct 25, 2017

BUY
$129.47 - $135.38 $442,010 - $462,187
3,414
3,414 $444,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $430B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cortland Associates Inc Portfolio

Follow Cortland Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cortland Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cortland Associates Inc with notifications on news.